Jon Favreau’s The Jungle Book, the latest offering from Disney’s live-action studio, is doing huge business in its debut at the North American box office, grossing $32.4 million on Friday for a projected $87 million-$90 million weekend, one of the top openings of all time for the month of April.
The movie’s better-than-expected performance — fueled by stellar reviews and an A CinemaScore — is yet another victory for Disney as it reimagines its classic titles. At this pace, the $175 tentpole will come ahead of fellow Disney titles Cinderella ($67.9 million), Oz the Great and Powerful ($79.1 million and Maleficent ($69.4 million).
Jungle Book is a reimagining of Rudyard Kipling’s eponymous book about an orphaned human boy whose guardians are animals. The live-action/CGI hybrid introduces Neel Sethi as Mowgli and features the voices of Bill Murray, Idris Elba, Ben Kingsley, Lupita Nyong’o and Scarlett Johansson.
Disney opens the movie in 4,208 theaters in North America; more than 3,000 of those will offer the film in a variety of premium formats, including 4D, 3D and Imax. Overseas, The Jungle Book already has grossed north of $30 million after opening in a handful of markets last weekend. It opens in other counties this weekend — including China, the U.K., France, Germany and Mexico — and could take in $75 million or more internationally.
The Jungle Book already has grossed $57.1 million from its first foreign markets, including doing record-breaking business in India — where Hollywood entries typically have a tough time — and Russia.
Two other films open this weekend, Ice Cube’s Barbershop: The Next Cut and the older-skewing action thriller Criminal, starring Kevin Costner and Tommy Lee Jones.
Boosted by strong reviews and an A- CinemaScore, Barbershop 3 is looking at debut in the $19 million range-$20 million range for New Line and MGM after earning $7 million Friday, somewhat behind expectations but good enough for the No. 2 spot.
Criminal is struggling in its debut, with a projected weekend gross of $6 million-$7 million.
More Must-Read Stories From TIME
- How an Online Pharmacy Sold Millions Worth Of Dubious COVID-19 Drugs — While Patients Paid the Price
- Why Literally Millions of Americans Are Quitting Their Jobs
- Meet the Women Participating in the Study That Could Change Future of Breast Cancer
- Inside the Battle for the Hearts and Minds of Tomorrow's Business Leaders
- An Innovative Washington Law Aims to Get Foreign-Trained Doctors Back in Hospitals
- Why the Ex-Husband of a Missing Chinese Billionaire Is Risking All to Tell Their Story
- Timothée Chalamet Wants You to Wear Your Heart on Your Sleeve